RxDataLab

Primary-source monitoring for the business of biotech

We build curated data infrastructure for BD, investor, and strategy teams. We cover 500+ companies and 450K+ trials, linked to SEC filings, insider activity, and hedge fund positioning. If you'd like a platform trial or want to discuss a custom monitoring setup for your coverage universe, reach out.